Thymol and carvacrol induce autolysis, stress, growth inhibition and reduce the biofilm formation by Streptococcus mutans
© The Author(s) 2017
Received: 6 February 2017
Accepted: 13 February 2017
Published: 23 February 2017
Organic compounds from plants are an attractive alternative to conventional antimicrobial agents. Therefore, two compounds namely M-1 and M-2 were purified from Origanum vulgare L. and were identified as carvacrol and thymol, respectively. Antimicrobial and antibiofilm activities of these compounds along with chlorhexidine digluconate using various assays was determined against dental caries causing bacteria Streptococcus mutans. The IC50 values of carvacrol (M-1) and thymol (M-2) against S. mutans were 65 and 54 µg/ml, respectively. Live and dead staining and the MTT assays reveal that a concentration of 100 µg/ml of these compounds reduced the viability and the metabolic activity of S. mutans by more than 50%. Biofilm formation on the surface of polystyrene plates was significantly reduced by M-1 and M-2 at 100 µg/ml as observed under scanning electron microscope and by colorimetric assay. These results were in agreement with RT-PCR studies. Wherein exposure to 25 µg/ml of M-1 and M-2 showed a 2.2 and 2.4-fold increase in Autolysin gene (AtlE) expression level, respectively. While an increase of 1.3 and 1.4 fold was observed in the super oxide dismutase gene (sodA) activity with the same concentrations of M-1 and M-2, respectively. An increase in the ymcA gene and a decrease in the gtfB gene expression levels was observed following the treatment with M-1 and M-2. These results strongly suggest that carvacrol and thymol isolated from O. vulgare L. exhibit good bactericidal and antibiofilm activity against S. mutans and can be used as a green alternative to control dental caries.
KeywordsThymol Carvacrol Oral hygiene Alternative antimicrobials S. mutans
The oral cavity is a complex microbial environment hosting around 600 different bacterial species and many of these bacteria are now being associated with oral diseases (Dewhirst et al. 2010; Moore and Moore 1994; Wade 2013). Dental diseases incur substantial economic losses globally accounting to 298 billion US dollar per year which is 4.6% of the total global health expenditure (Listl et al. 2015). The evidence is also now available that the recurring infections of these oral microorganisms result in a number of systemic diseases further adding to the economic losses and loss of life (Khan et al. 2015; Li et al. 2000). One of the most important etiological agents of dental caries is Streptococcus mutans (Loesche 1986). In addition to being classically associated with dental caries, this bacterium also causes other systemic diseases such as ulcerative colitis, endocarditis and septicemia (Kojima et al. 2012; Nobbs 2016; Robbins et al. 1977; Tunkel and Sepkowitz 2002). The biofilm formation by S. mutans and its ability to promote the biofilm formation by other oral bacteria also makes it more difficult to treat the infections of S. mutans (Ahn et al. 2008; Klein et al. 2015; Krzyściak et al. 2014). Therefore, for a good oral hygiene, it is very important to control the growth of S. mutans in the oral cavity. Furthermore, the unwarranted and overuse of the antibiotics in dentistry has resulted in the drug resistance among commensal as well as pathogenic bacteria of the oral cavity including S. mutans (Leistevuo et al. 2000; Sweeney et al. 2004). Therefore, alternatives to conventional antimicrobial agents are highly and urgently required. Among, the alternative antimicrobials are engineered nanomaterials, plant-based materials, bacteriocins and phage-based therapies (Allen et al. 2014; Khan et al. 2016b, c; Rose et al. 2014).
Plant based materials, especially from edible plants, are an effective alternative antimicrobials especially those classified as GRAS (generally recognized as safe) (Burdock and Carabin 2004). Two such commonly used edible plants in traditional medicine since ancient times are Origanum and Thymus (Craig 1999; Nostro and Papalia 2012). Essential oils from these plants have been shown to exhibit significant antimicrobial activities and their antimicrobial activity against food-borne pathogens have been already tested (Chorianopoulos et al. 2004). The major components in the essential oils of Origanum and Thymus are the phenolic monoterpene carvacrol and its isomeric form Thymol (Chorianopoulos et al. 2004; Fachini-Queiroz et al. 2012). Both Carvacrol and Thymol have been classified as GRAS and their use in food has been approved by European Parliament and Council (Hyldgaard et al. 2012). The antimicrobial activity of thymol and carvacrol have been reported against foodborne pathogens such as Clostridium perfringens, Escherichia coli O157:H7 and Listeria innocua (Du et al. 2015; Guarda et al. 2011). The mechanism behind this antibacterial activity includes permeabilization and depolarization of the cytoplasmic membrane, by reducing the pH gradient across the cytoplasmic membrane. This reduction in pH gradient also adversely affects the proton motive force leading to the depletion of the intracellular ATP subsequently leading to cell death (Ultee et al. 2002; Xu et al. 2008). It is also concluded in the same study that the phenolic hydroxyl group of thymol and carvacrol plays an important role in its antimicrobial activity (Ultee et al. 2002).
In this paper, we report a detailed study on antimicrobial and antibiofilm activities of two natural compounds M-1 and M-2 isolated from O. vulgare L. Moreover, comparison of antimicrobial and antibiofilm activities of these two compounds with chlorhexidine digluconate a commercially used antiplaque compound and clove oil is also discussed in detail in this study.
Materials and methods
Plant material and isolation of essential oils
The aerial parts of O. vulager L. grown in two different agro-climatic conditions were collected from Saudi Arabia and Jordan in the month of March 2014 and identified by Dr. Jacob Thomas Pandalayil (a botanical taxonomist from the Herbarium Division, College of Science, King Saud University, Riyadh, KSA). Stems of O. vulgare L. aerial parts from Saudi Arabia and Jordan were separated and subjected to hydro-distillation separately in a conventional Clevenger-type apparatus for 3 h according to the methods described previously (2016) to give light yellow colour oils with oil yield of 0.40 and 0.24% respectively.
Bacterial strains and culture media
The culture of Streptococcus mutans ATCC 25175 was purchased from American Type Culture Collection (ATCC). Brain heart infusion broth (BHI; Mast Group, Bootle, UK) with 2% sucrose was used for routine culture. For longer preservation and storage, the strain was stored at −80 °C in 20% glycerol.
Antimicrobial activity of M-1 and M-2 against S. mutans
The antimicrobial activity of M-1 and M-2 were determined by two methods namely microdilution method and plate count method. For microdilution method, 90 µl of BHI broth with 2% sucrose was added to each well in a 96 well plate. M-1, M-2, and clove oil were added to final concentrations of 1000, 500, 250, 125, 62.5, 31.25, 15.6 and 0 µg/ml. While, as a positive control chlorhexidine digluconate was added to final concentrations of 10.0, 5.0, 2.5, 0.125, 0.0625, 0.031, 0.015 and 0 µg/ml. To these wells 10 µl of S. mutans ATCC 25175 cultures grown overnight in BHI broth were added. And the 96 well plate was incubated at 37 °C for 24 h.
For plate count assays M-1, M-2 and clove oil were added to tubes containing 5 ml BHI broth with 2% sucrose to final concentrations of 200, 100, 50 and 25 µg/ml. Aliquots of 500 µl from the cultures of S. mutans ATCC 25175 grown to log phase were added to these tubes. Chlorhexidine digluconate was added to final concentrations of 10.0, 5.0 and 0 µg/ml as a positive control. Tubes without any test compound were used as a control. The cultures were incubated at 37 °C on a shaker with 150 rpm for 12 h. Following incubation, appropriate dilutions of treated and untreated cells were spread on BHI agar plates. The plates were incubated at 37 °C for 3 d. Finally, colony-forming units (CFUs) were counted and recorded.
Assessing bacterial viability by MTT assay
The change in bacterial viability after treatment with test compounds was determined using MTT assay as described by Mshana et al. (1998) S. mutans ATCC 25175 was grown in BHI broth containing 25, 50, 100 and 200 µg/ml of M-1, M-2, and clove oil for 4–6 h at 37 °C. Cells grown with various concentrations of chlorhexidine digluconate (2.5, 5, 10 and 20 µg/ml) were taken as positive control. An aliquot of 40 µl from this culture was transferred to wells in 96 well plates in triplicates. Ten microliters of the MTT (Sigma, USA) solution in PBS (5 mg/ml, pH 7.0) was then added to each well containing bacterial cells. Plates were incubated at 37 °C for 4 h. Following incubation 50 µl of a lysis buffer (20% sodium dodecyl sulfate in 50% N, N-dimethylformamide; pH 4.7) was added to the wells and the plates were further incubated at 37 °C for overnight. Finally, the mixture in the wells was mixed by pipetting and Absorbance at 570 nm was measured using Multiskan microtitre plate reader (Multiskan Ascent, Labsystems, Finland).
Live and dead staining
Streptococcus mutans ATCC 25175 was grown either with 25 µg/ml of M-1, M-2, and clove oil or with 2.5 µg/ml of chlorhexidine digluconate for 8 h at 37 °C on a shaker. Following treatment with test compounds, cells were harvested by centrifugation at 900×g and were washed with PBS buffer once, and finally suspended again in sterile PBS buffer (pH 7.5). Live and dead staining was performed using LIVE/DEAD® BacLight™ Bacterial Viability Kit (Molecular Probes, Life technologies, USA) following the instructions of the manufacturer. Cells stained as above were observed under a fluorescence microscope (Nikon Eclipse 80i; Nikon Co., Japan) and cells appearing red and green in colour were recorded as dead and total cells, respectively. Ten fields were counted for each treatment and the percentage of dead cells was calculated by comparing the population of dead cells to total cells in the same field.
Quantitative assessment of biofilm formation
The standard protocol of Burton et al. (2007) was used to quantitate the inhibition of biofilm formation on 48 well polystyrene plates (Nunc, Denmark) in the presence of the test compounds. In each well 900 µl of sterile BHI medium and 100 µl of exponentially growing cells of S. mutans ATCC 25175 were added. M-1, M-2, and clove oil were added to final concentrations of 200, 100, 50 and 25 µg/ml. As a positive control chlorhexidine digluconate was added to a final concentration of 10, 5, 2.5 and 1.2 µg/ml. Cultures without any test compounds were taken as control. Plates were then incubated for 24 h at 37 °C. Following incubation medium and the floating cells were gently and completely removed using a micropipette. The biofilm at the bottom of the wells was gently washed with PBS buffer (pH 7.4) three times. Biofilms were stained with 0.4% crystal violet (500 µl) dye for 15 min at room temperature. Wells were washed gently 3 times with PBS buffer to remove unbound dye. The crystal violet retained by the biofilm was solubilized in 500 µl of 33% acetic acid. Finally, absorption was determined at 620 nm using a microtitre plate reader (Multiskan, Finland).
Scanning electron microscopy of biofilm inhibition
Biofilms on the surface of polystyrene plates were grown in the presence of test compounds as detailed above. For biofilm formation assay S. mutans was grown with 100 µg/ml of clove oil, M-1, and M-2. Culture medium was removed with the help of a micropipette and the biofilm was washed gently with PBS as described above. The biofilms were stained with the fumes of 1% OsO4 at room temperature for 3 h and were rinsed three times with milli-Q. Samples were completely dehydrated with series of ethanol (30, 50, 70, 80, 90, 95 and 100%) and these dehydrated samples were sputter coated with platinum using an SPI-Module line of modular sputter coater. Samples were then observed under Scanning electron microscope (JSM-6380; JEOL), at an accelerating voltage of 10-KV and a magnification of 10,000×. Ten fields for each sample were recorded and compared.
Quantitative real-time PCR
Primers used for RT-PCR in this study
Product size (~bp)
All the tests were performed in triplicate and the data were expressed as the mean ± standard error of at least three independent experiments. A unpaired t test of GraphPad software was used to calculate p values. p values that were considered significant for different tests are provided in the figure captions.
Isolation and identification of major compounds M-1 and M-2 from essential oils
Antimicrobial activity of test compounds by microdilution method
Antimicrobial activity was determined by using microdilution method. S. mutans was grown with 1000, 500, 250, 125, 62.5, 31, and 15 and µg/ml of clove oil, M-1, and M-2. Highest antimicrobial activity against S. mutans ATCC 25175 was observed with thymol (M-2), where almost no growth was observed with 125 µg/ml of M-2 or thymol. While for M-1or carvacrol complete inhibition of growth was observed with 250 µg/ml. Clove oil appeared to be the least effective in inhibiting the growth of S. mutans wherein even with 1000 µg/ml of concentration complete inhibition of the growth was not observed. Chlorhexidine digluconate which was used as a positive control inhibited the growth of S. mutans completely at a concentration of 10 µg/ml and was found to be almost twenty times more effective than carvacrol and thymol.
Antimicrobial activity of test compounds by dilution plating method
Change in bacterial viability as determined by MTT assay
Change in bacterial viability as determined by dead/live staining
Quantitative and qualitative assay for biofilm inhibition
Real-time PCR analysis of the genes involved in cell death, stress and biofilm formation
Change in the expression of six genes namely autolysin like genes AtlE (N-acetylmuramoyl-l-alanine amidase type), and AtlA like genes, Polyribonucleotide nucleotidyl transferase as a marker of general stress (PnpA), superoxide dismutase gene (SOD), ymcA and gtfB genes was studied to check the cell death, general stress and biofilm formation activities. Since it was found that two genes PnpA like and AtlA like genes were not sufficiently amplified in PCR assay using genomic DNA from S. mutans as template, these two genes were not used in RT-PCR studies. Furthermore, the sequence of the PCR products amplified using the PCR primers confirms that these primers are specifically binding to the target genes (Additional file 1).
Essential oils from edible plants especially those classified as GRAS are one of the safe alternatives to traditional antibiotics (Kalemba and Kunicka 2003). But the commercialization of these plant-based products is often hampered by the inability to purify bioactive compounds from these plants. Two such compounds, thymol, and carvacrol are the main constituents of O. vulgare L., both compounds are known to exhibit antimicrobial activity against a number of pathogens (Chorianopoulos et al. 2004; Thosar et al. 2013; Ultee et al. 2002). Interestingly, an in vitro study has demonstrated that thymol, and carvacrol show selectively higher antimicrobial activity against the tested pathogenic bacteria (Escherichia coli, Clostridium perfringens, and Salmonella) than the beneficial probiotic bacteria Lactobacillus (Du et al. 2015). When thymol and carvacrol were tested in vivo for their efficacy to inhibit C. perfringens in broilers it was found that although the population of the pathogen was not reduced significantly but the treatment alleviated intestinal lesions caused by these pathogens (Du et al. 2015). The same group (Du et al. 2016) in their in vivo study on broilers has further demonstrated many beneficial effects of thymol and carvacrol including an increase in feed conversion efficiency, increase in immunity against virus and tumor. It has been reviewed earlier also that herbs that serve as a primary source of these essential oils exhibit anticancer activities (Craig 1999). Hence, thymol and carvacrol in addition to possessing desired antimicrobial activity also have known health benefits making these essential oils a promising alternative antimicrobial agent.
Dental caries and periodontal diseases are most prevalent microbial diseases and S. mutans is one of the most important bacterium involved in dental caries (Loesche 1986; Selwitz et al. 2007). To keep a good oral hygiene, it is very important to check the growth of S. mutans. However, over and unwarranted use of antibiotics has also resulted in the development of antibiotic resistance in these pathogens (Leistevuo et al. 2000). Since, thymol and carvacrol exhibit good antimicrobial activity these essential oils were purified from O. vulgare L. and their antimicrobial activity against S. mutans was determined. Furthermore, the antimicrobial activity of thymol and carvacrol was compared with clove oil, a traditionally used essential oil in dentistry, and with chlorhexidine digluconate a widely used compound in mouthwashes (McBain et al. 2003; Thosar et al. 2013). To our knowledge, this is the first such detailed report on the antimicrobial and antibiofilm activity of thymol and carvacrol against S. mutans.
IC50 values of thymol, carvacrol, clove oil and chlorhexidine digluconate were found to be 54, 65, 306 and 4.9 µg/ml, respectively in this study. These results were further confirmed by MTT assay wherein 200 µg/ml of thymol and carvacrol reduced the cell viability by 87 ± 6 and 74 ± 8%, respectively. While, chlorhexidine digluconate resulted in the death of 37 ± 3% of the cells at a very low concentration of 2.5 µg/ml. In earlier studies, the essential oils from thyme and origanum exhibited high MIC values in a range of 256–512 μg/ml against group A Streptococci (GAS) (Magi et al. 2015). While in the same study commercially available carvacrol exhibited a MIC value in the range of 64–256 µg/ml against GAS (Magi et al. 2015). Decontamination of lettuce using a solution of carvacrol and thymol was also reported since these essential oils are edible (Bagamboula et al. 2004). In another study, the antimicrobial activity of microencapsulated carvacrol and thymol was determined against many microorganisms including foodborne pathogens Escherichia coli O157:H7, Staphylococcus aureus, and Listeria innocua. The MIC of the microencapsulated carvacrol and thymol against these organisms were in the range of 225–375 ppm (Guarda et al. 2011). The positive control chlorhexidine digluconate suppressed the growth and viability of S. mutans at much lower concentrations as found in earlier studies also (McBain et al. 2003). While, the MIC values of eugenol a main constiuent of clove oil against S. mutans were reported to be 100 µg/ml (Freires et al. 2015).
As far as the mechanism of the antimicrobial activity is concerned, it is suggested that these compounds are involved in the permeabilization and depolarization of the cytoplasmic membrane. Which results in the reduction of the pH gradient across the cytoplasmic membrane. This lowering of pH gradient leads to the disturbance in proton motive force subsequently leading to the depletion of intracellular ATP level and cell death (Ultee et al. 2002). The increase in the number of dead cells following the treatment with thymol and carvacrol was also observed in this study (Figs. 3b, 4) through propidium iodide staining a dye that can only penetrate into the cells having compromised cell wall. Deformed and lysed cells as observed under scanning electron microscope further confirms that thymol and carvacrol results in the lysis of the cells. The overexpression of autolysin genes involved in the restructuring of the cell wall further confirms these findings. Our results also show the over expression sodA and ymcA genes, suggesting that treatment with thymol and carvacrol induces general and oxidative stress in the cells. Chlorhexidine digluconate also exhibit its antimicrobial activity primarily through membrane disruption (McBain et al. 2003). Inhibition of glycosidic and proteolytic enzymes by chlorhexidine digluconate is also reported (Hastings 2000). Although carvacrol and thymol also disrupt the cell membrane but these essential oils are not water-soluble which may adversely affect their penetration into the bacterial cells resulting in lower activity. This argument is also supported by the findings that nano form of thymol exhibit better antimicrobial activity than the native form because of the improved dispersibility (Shah et al. 2012).
Another important trait of pathogenicity is biofilm formation. Biofilms exhibit greater resistance to antimicrobial agents and are difficult to treat (Ahn et al. 2008; Curtis et al. 2011). Therefore, the antibiofilm activities of carvacrol (M-1) and thymol (M-2) against S. mutans was determined. The results of crystal violet assay and the qualitative examination of the biofilms under SEM (Fig. 6) suggest that the two compounds significantly reduce the biofilm formation by S. mutans. In gene expression studies also the downregulation of glycosyl transferase B (gtfB) gene suggests the inhibition of biofilm formation. Previously the antibiofilm activity of thymol and carvacrol against Pseudomonas aeruginosa has been reported (Ceylan and Ugur 2015). Chlorhexdine digluconate also reduced the biofilm formation at a concentration of 10 µg/ml. Inhibition of biofilm formation by chlorhexidine has been reported in in vivo studies also (Bailón-Sánchez et al. 2014). As far as the antimicrobial and antibiofilm activities of clove oil are concerned clove oil was found to be least effective.
Results presented in this study strongly suggest that thymol and carvacrol exhibit significant antimicrobial and antibiofilm activities against S. mutans. Since these compounds are derived from edible plants classified as GRAS, these essential oils can be used in mouthwashes or toothpastes for controlling oral bacteria and for maintaining good oral hygiene. Furthermore, unlike chlorhexidine digluconate, thymol and carvacrol have some health benefits in addition to the desired antimicrobial activity. Although, chlorhexidine digluconate is widely used and do not have any known health hazard but its effect on taste buds is well known (Helms et al. 1995).
- CAR (M-1):
- THY (M-2):
(3-(4, 5-Dimethylthiazol-2-yl)-2, 5-Diphenyltetrazolium Bromide)
real time PCR
super oxide dismutase A
N-acetylmuramoyl-l-alanine amidase type
American Type Culture Collection
brain heart infusion broth
revolutions per minute
polymerase chain reaction
gas chromatography mass spectrometry
gas chromatography—flame ionization detector
nuclear magnetic resonance spectroscopy
minimum inhibitory concentration
generally recognized as safe
STK, main author designed and executed the study. MK, he collected the plant sample and isolated and identified thymol and carvacrol therefrom. JA, he did RNA isolation and RT-PCR studies. RW, he helped in microbiological studies. OHAE carried out the SEM studies. JM, HZA and AAAK, arranged funding and helped in preparing the manuscript. All authors read and approved the final manuscript.
Authors would like to thank Twasol Research Excellence Program (TRE Program), King Saud University, Saud Arabia for support.
The authors declare that they have no competing interests.
Availability of data and materials
All the data are provided as an excel sheet except for the data on purification and characterization of carvacrol and thymol that will be published elsewhere.
This article does not contain any studies with human participants or animals performed by any of the authors.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Ahn SJ, Burne RA (2006) The atlA operon of Streptococcus mutans: role in autolysin maturation and cell surface biogenesis. J Bacteriol 188:6877–6888. doi:10.1128/JB.00536-06 View ArticlePubMedPubMed CentralGoogle Scholar
- Ahn SJ, Wen ZT, Brady LJ, Burne RA (2008) Characteristics of biofilm formation by Streptococcus mutans in the presence of saliva. Infect Immun 76:4259–4268. doi:10.1128/IAI.00422-08 View ArticlePubMedPubMed CentralGoogle Scholar
- Ajdić D, McShan WM, McLaughlin RE, Savić G, Chang J, Carson MB, Primeaux C, Tian R, Kenton S, Jia H, Lin S, Qian Y, Li S, Zhu H, Najar F, Lai H, White J, Roe BA, Ferretti JJ (2002) Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci USA 99:14434–14439. doi:10.1073/pnas.172501299 View ArticlePubMedPubMed CentralGoogle Scholar
- Allen HK, Trachsel J, Looft T, Casey TA (2014) Finding alternatives to antibiotics. Ann NY Acad Sci 1323:91–100. doi:10.1111/nyas.12468 View ArticlePubMedGoogle Scholar
- Bagamboula CF, Uyttendaele M, Debevere J (2004) Inhibitory effect of thyme and basil essential oils, carvacrol, thymol, estragol, linalool and p-cymene towards Shigella sonnei and S. flexneri. Food Microbiol 21:33–42. doi:10.1016/s0740-0020(03)00046-7 View ArticleGoogle Scholar
- Bailón-Sánchez ME, Baca P, Ruiz-Linares M, Ferrer-Luque CM (2014) Antibacterial and anti-biofilm activity of AH plus with chlorhexidine and cetrimide. J Endod 40:977–981View ArticlePubMedGoogle Scholar
- Burdock GA, Carabin IG (2004) Generally recognized as safe (GRAS): history and description. Toxicol Lett 150:3–18. doi:10.1016/j.toxlet.2003.07.004 View ArticlePubMedGoogle Scholar
- Burton E, Yakandawala N, LoVetri K, Madhyastha MS (2007) A microplate spectrofluorometric assay for bacterial biofilms. J Ind Microbiol Biotechnol 34:1–4. doi:10.1007/s10295-006-0086-3 View ArticlePubMedGoogle Scholar
- Carabetta VJ, Tanner AW, Greco TM, Defrancesco M, Cristea IM, Dubnau D (2013) A complex of YlbF, YmcA and YaaT regulates sporulation, competence and biofilm formation by accelerating the phosphorylation of Spo0A. Mol Microbiol 88:283–300. doi:10.1111/mmi.12186 View ArticlePubMedPubMed CentralGoogle Scholar
- Ceylan O, Ugur A (2015) Chemical composition and anti-biofilm activity of Thymus sipyleus BOISS. subsp. sipyleus BOISS. var. davisianus RONNIGER essential oil. Arch Pharm Res 38:957–965. doi:10.1007/s12272-014-0516-0 View ArticlePubMedGoogle Scholar
- Chorianopoulos N, Kalpoutzakis E, Aligiannis N, Mitaku S, Nychas G-J, Haroutounian SA (2004) Essential oils of Satureja, Origanum, and Thymus species: chemical composition and antibacterial activities against foodborne pathogens. J Agric Food Chem 52:8261–8267. doi:10.1021/jf049113i View ArticlePubMedGoogle Scholar
- Craig WJ (1999) Health-promoting properties of common herbs. Am J Clin Nutr 70:491S–499SPubMedGoogle Scholar
- Curtis MA, Zenobia C, Darveau RP (2011) The relationship of the oral microbiotia to periodontal health and disease. Cell Host Microbe 10:302–306. doi:10.1016/j.chom.2011.09.008 View ArticlePubMedPubMed CentralGoogle Scholar
- Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, Lakshmanan A, Wade WG (2010) The human oral microbiome. J Bacteriol 192:5002–5017. doi:10.1128/JB.00542-10 View ArticlePubMedPubMed CentralGoogle Scholar
- Du E, Gan L, Li Z, Wang W, Liu D, Guo Y (2015) In vitro antibacterial activity of thymol and carvacrol and their effects on broiler chickens challenged with Clostridium perfringens. J Anim Sci Biotechnol 6:58. doi:10.1186/s40104-015-0055-7 View ArticlePubMedPubMed CentralGoogle Scholar
- Du E, Wang W, Gan L, Li Z, Guo S, Guo Y (2016) Effects of thymol and carvacrol supplementation on intestinal integrity and immune responses of broiler chickens challenged with Clostridium perfringens. J Anim Sci Biotechnolo 7:19. doi:10.1186/s40104-016-0079-7 View ArticleGoogle Scholar
- Fachini-Queiroz FC, Kummer R, Estevão-Silva CF, Carvalho MD, Cunha JM, Grespan R, Bersani-Amado CA, Cuman RK (2012) Effects of thymol and carvacrol, constituents of Thymus vulgaris L. essential oil, on the inflammatory response. Evid Based Complement Alternat Med. doi:10.1155/2012/657026 PubMedPubMed CentralGoogle Scholar
- Freires IA, Denny C, Benso B, de Alencar SM, Rosalen PL (2015) Antibacterial activity of essential oils and their isolated constituents against cariogenic bacteria: a systematic review. Molecules 20:7329–7358View ArticlePubMedGoogle Scholar
- Guarda A, Rubilar JF, Miltz J, Galotto MJ (2011a) The antimicrobial activity of microencapsulated thymol and carvacrol. Int J Food Microbiol 146:144–150. doi:10.1016/j.ijfoodmicro.2011.02.011 View ArticlePubMedGoogle Scholar
- Guarda A, Rubilar JF, Miltz J, Galotto MJ (2011b) The antimicrobial activity of microencapsulated thymol and carvacrol. Int J Food Microbiol 146:144–150. doi:10.1016/j.ijfoodmicro.2011.02.011 View ArticlePubMedGoogle Scholar
- Hastings DC (2000) Non-antibiotic plaque chemotherapy. In: Newman HN, Wilson M (eds) Dental plaque revisited: oral biofilms in health and disease. Bioline Press, Cardiff, pp 523–548Google Scholar
- Helms JA, Della-Fera MA, Mott AE, Frank ME (1995) Effects of chlorhexidine on human taste perception. Arch Oral Biol 40:913–920View ArticlePubMedGoogle Scholar
- Hyldgaard M, Mygind T, Meyer RL (2012) Essential oils in food preservation: mode of action, synergies, and interactions with food matrix components. Front Microbiol 3:12. doi:10.3389/fmicb.2012.00012 View ArticlePubMedPubMed CentralGoogle Scholar
- Kalemba D, Kunicka A (2003) Antibacterial and antifungal properties of essential oils. Curr Med Chem 10:813–829View ArticlePubMedGoogle Scholar
- Khan ST, Al-Khedhairy AA, Musarrat J (2015) ZnO and TiO2 nanoparticles as novel antimicrobial agents for oral hygiene: a review. J Nanopart Res 17:276. doi:10.1007/s11051-015-3074-6 View ArticleGoogle Scholar
- Khan M, Al-Saleem MSM, Alkhathlan HZ (2016a) A detailed study on chemical characterization of essential oil components of two Plectranthus species grown in Saudi Arabia. J Saudi Chem Soci 20:711–721. doi:10.1016/j.jscs.2016.03.006 View ArticleGoogle Scholar
- Khan ST, Ahmad J, Ahamed M, Musarrat J, Al-Khedhairy AA (2016b) Zinc oxide and titanium dioxide nanoparticles induce oxidative stress, inhibit growth, and attenuate biofilm formation activity of Streptococcus mitis. J Biol Inorg Chem 21:295–303. doi:10.1007/s00775-016-1339-x View ArticlePubMedGoogle Scholar
- Khan ST, Musarrat J, Al-Khedhairy AA (2016c) Countering drug resistance, infectious diseases, and sepsis using metal and metal oxides nanoparticles: current status. Coll Surf B Biointerfaces 146:70–83. doi:10.1016/j.colsurfb.2016.05.046 View ArticleGoogle Scholar
- Klein MI, Hwang G, Santos PHS, Campanella OH, Koo H (2015) Streptococcus mutans-derived extracellular matrix in cariogenic oral biofilms. Front Cell Infect Microbiol. doi:10.3389/fcimb.2015.00010 PubMedPubMed CentralGoogle Scholar
- Kojima A, Nakano K, Wada K, Takahashi H, Katayama K, Yoneda M, Higurashi T, Nomura R, Hokamura K, Muranaka Y, Matsuhashi N, Umemura K, Kamisaki Y, Nakajima A, Ooshima T (2012) Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis. Sci Rep 2:332. doi:10.1038/srep00332 View ArticlePubMedPubMed CentralGoogle Scholar
- Krzyściak W, Jurczak A, Kościelniak D, Bystrowska B, Skalniak A (2014) The virulence of Streptococcus mutans and the ability to form biofilms. Eur J Clin Microbiol Infect Dis 33:499–515. doi:10.1007/s10096-013-1993-7 View ArticlePubMedGoogle Scholar
- Leistevuo J, Järvinen H, Österblad M, Leistevuo T, Huovinen P, Tenovuo J (2000) Resistance to mercury and antimicrobial agents in Streptococcus mutans isolates from human subjects in relation to exposure to dental amalgam fillings. Antimicrob Agents Chemother 44:456–457View ArticlePubMedPubMed CentralGoogle Scholar
- Li X, Kolltveit KM, Tronstad L, Olsen I (2000) Systemic diseases caused by oral infection. Clin Microbiol Rev 13:547–558View ArticlePubMedPubMed CentralGoogle Scholar
- Listl S, Galloway J, Mossey PA, Marcenes W (2015) Global economic impact of dental diseases. J Dent Res 94:1355–1361. doi:10.1177/0022034515602879 View ArticlePubMedGoogle Scholar
- Loesche WJ (1986) Role of Streptococcus mutans in human dental decay. Microbiol Rev 50:353–380PubMedPubMed CentralGoogle Scholar
- Magi G, Marini E, Facinelli B (2015) Antimicrobial activity of essential oils and carvacrol, and synergy of carvacrol and erythromycin, against clinical, erythromycin-resistant Group A Streptococci. Front Microbiol 6:165. doi:10.3389/fmicb.2015.00165 View ArticlePubMedPubMed CentralGoogle Scholar
- McBain AJ, Bartolo RG, Catrenich CE, Charbonneau D, Ledder RG, Gilbert P (2003) Effects of a chlorhexidine gluconate-containing mouthwash on the vitality and antimicrobial susceptibility of in vitro oral bacterial ecosystems. Appl Environ Microbiol 69:4770–4776View ArticlePubMedPubMed CentralGoogle Scholar
- Moore WEC, Moore LVH (1994) The bacteria of periodontal diseases. Periodontology 2000(5):66–77. doi:10.1111/j.1600-0757.1994.tb00019.x View ArticleGoogle Scholar
- Mshana RN, Tadesse G, Abate G, Miorner H (1998) Use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol 36:1214–1219PubMedPubMed CentralGoogle Scholar
- Nobbs A (2016) Getting to the heart of the matter: role of Streptococcus mutans adhesin Cnm in systemic disease. Virulence. doi:10.1080/21505594.2016.1212157 PubMedGoogle Scholar
- Nostro A, Papalia T (2012) Antimicrobial activity of carvacrol: current progress and future prospectives. Recent Pat Antiinfect Drug Discov 7:28–35View ArticlePubMedGoogle Scholar
- Robbins N, Szilagyi G, Tanowitz HB, Luftschein S, Baum SG (1977) Infective endocarditis caused by Streptococcus mutans. A complication of idiopathic hypertrophic subaortic stenosis. Arch Intern Med 137:1171–1174View ArticlePubMedGoogle Scholar
- Rose T, Verbeken G, Vos DD, Merabishvili M, Vaneechoutte M, Lavigne R, Jennes S, Zizi M, Pirnay JP (2014) Experimental phage therapy of burn wound infection: difficult first steps. Int J Burns Trauma 4:66–73PubMedPubMed CentralGoogle Scholar
- Selwitz RH, Ismail AI, Pitts NB (2007) Dental caries. Lancet 369:51–59. doi:10.1016/S0140-6736(07)60031-2 View ArticlePubMedGoogle Scholar
- Shah B, Davidson PM, Zhong Q (2012) Nanocapsular dispersion of thymol for enhanced dispersibility and increased antimicrobial effectiveness against Escherichia coli O157:H7 and Listeria monocytogenes in model food systems. Appl Environ Microbiol 78:8448–8453View ArticlePubMedPubMed CentralGoogle Scholar
- Sweeney LC, Dave J, Chambers PA, Heritage J (2004) Antibiotic resistance in general dental practice–a cause for concern? J Antimicrob Chemother 53:567–576. doi:10.1093/jac/dkh137 View ArticlePubMedGoogle Scholar
- Thosar N, Basak S, Bahadure RN, Rajurkar M (2013) Antimicrobial efficacy of five essential oils against oral pathogens: an in vitro study. Eur J Dent 7:S71–S77. doi:10.4103/1305-7456.119078 View ArticlePubMedPubMed CentralGoogle Scholar
- Tunkel AR, Sepkowitz KA (2002) Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 34:1524–1529. doi:10.1086/340402 View ArticlePubMedGoogle Scholar
- Ultee A, Bennik MH, Moezelaar R (2002) The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl Environ Microbiol 68:1561–1568View ArticlePubMedPubMed CentralGoogle Scholar
- Wade WG (2013) The oral microbiome in health and disease. Pharmacol Res 69:137–143. doi:10.1016/j.phrs.2012.11.006 View ArticlePubMedGoogle Scholar
- Xu J, Zhou F, Ji BP, Pei RS, Xu N (2008) The antibacterial mechanism of carvacrol and thymol against Escherichia coli. Lett Appl Microbiol 47:174–179. doi:10.1111/j.1472-765X.2008.02407.x View ArticlePubMedGoogle Scholar
- Yamamoto Y, Higuchi M, Poole LB, Kamio Y (2000) Role of the dpr product in oxygen tolerance in Streptococcus mutans. J Bacteriol 182:3740–3747View ArticlePubMedPubMed CentralGoogle Scholar